Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Infections × monalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Neoplasm Metastasis 1 Lung Neoplasms 1 Infections 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 COVID-19 1 Breast Neoplasms 1

Interventions

Voriconazole 4 Vancomycin 3 Fluconazole 3 Filgrastim 3 Ciprofloxacin 3 Trimethoprim, Sulfamethoxazole Drug Combination 2 Therapeutics 2 Piperacillin, Tazobactam Drug Combination 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Itraconazole 2 Granulocyte Colony-Stimulating Factor 2 Fosfomycin 2 Daptomycin 2 Cyclophosphamide 2 Cefazolin 2 Caspofungin 2 Antibiotic Prophylaxis 2 ziprasidone 1 threonic acid 1 telavancin 1 soybean oil, phospholipid emulsion 1 plerixafor 1 monalizumab 1 liposomal amphotericin B 1 lime 1 human papillomavirus vaccine, L1 type 16, 18 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 fludarabine phosphate 1 fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333914 2022-09-30

IMMUNONCOVID

Centre Leon Berard

Phase 2 Completed

COVID-19, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡